(VIANEWS) – Shares of ONWARD MEDICAL (BEL 20: ONWD.BR) rose by a staggering 28.33% in 21 sessions from €4.8 to €6.16 at 20:22 EST on Monday, after five consecutive sessions in a row of gains. BEL 20 is jumping 0.05% to €3,634.52, after two consecutive sessions in a row of gains.
ONWARD MEDICAL’s last close was €5.96, 27.58% below its 52-week high of €8.23.
About ONWARD MEDICAL
Onward Medical N.V., a medical technology company, focuses on developing therapies for spinal cord injuries in the Netherlands and internationally. The company engages in developing ARC-EX, an external non-invasive platform that consists of a wearable stimulator and wireless programmer; and ARCIM, an implantable platform, which consists of an implantable pulse generator and lead that is placed near the spinal cord. It also engages in developing Up-LIFT Trial to evaluate the safety and effectiveness of non-invasive electrical spinal cord stimulation to treat upper extremity functional deficits with chronic tetraplegia. The company was founded in 2014 and is headquartered in Eindhoven, Netherlands.
Earnings Per Share
As for profitability, ONWARD MEDICAL has a trailing twelve months EPS of €-1.14.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -48.44%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, ONWARD MEDICAL’s stock is considered to be oversold (<=20).
Moving Average
ONWARD MEDICAL’s worth is way above its 50-day moving average of €4.96 and way higher than its 200-day moving average of €5.56.
More news about ONWARD MEDICAL (ONWD.BR).
